Приказ основних података о документу
Combined molecular dynamics and virtual screening studies to identify novel sirtuin 2 inhibitors
dc.creator | Đoković, Nemanja | |
dc.creator | Nikolić, Katarina | |
dc.creator | Lahtela‐Kakkonen, Maija | |
dc.creator | Agbaba, Danica | |
dc.date.accessioned | 2023-07-06T09:19:15Z | |
dc.date.available | 2023-07-06T09:19:15Z | |
dc.date.issued | 2018 | |
dc.identifier.uri | https://farfar.pharmacy.bg.ac.rs/handle/123456789/4893 | |
dc.description.abstract | Sirtuins are highly conserved class of NAD+-dependent lysine deacetylases. Altered function of sirtuin 2 (Sirt2) is related to pathogenesis of cancer, inflammation and neurodegeneration, which makes Sirt2 very attractive drug target in novel epigenetic research [1]. A number of Sirt2 inhibitors have been recently developed, but for most of them are missing structural information of their interaction with the enzyme [2, 3]. Our molecular dynamic (MD) study was performed on recently resolved crystal structures of selective ligand-Sirt2 complexes [1]. In the MD study were defined significant interactions with novel inhibitors, one of key residues responsible for conformational stability of cofactor-binding pocket, and residue acting as gate-keeper for cofactor-binding loop. Some residues completely changed orientation after the MD simulation, compared to the starting crystal structures. This result indicates on the errors in the X-ray structures that may have influence on structure-based design of novel inhibitors. After clustering of MD trajectory, 20 conformations (centroids) from 20 clusters of Sirt2 have been selected as representative conformations for retrospective structure based virtual screening. The virtual screening performances were significantly improved by use of the ensemble of conformations, selected with this MD methodology, compared to screening against available X-ray structures. | sr |
dc.language.iso | en | sr |
dc.publisher | Section for Medicinal Chemistry of the Slovenian Pharmaceutical Society | sr |
dc.relation | info:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/172033/RS// | sr |
dc.rights | openAccess | sr |
dc.source | EFMC-ISMC, XXV EFMC International Symposium on Medicinal Chemistry, Book of Abstract | sr |
dc.title | Combined molecular dynamics and virtual screening studies to identify novel sirtuin 2 inhibitors | sr |
dc.type | conferenceObject | sr |
dc.rights.license | ARR | sr |
dc.citation.spage | 305 | |
dc.citation.epage | 305 | |
dc.description.other | XXV EFMC International Symposium on Medicinal Chemistry, Ljubljana, Slovenia, September 2-6, 2018 | |
dc.identifier.fulltext | http://farfar.pharmacy.bg.ac.rs/bitstream/id/13396/Combined_molecular_dynamics_pub_2018.pdf | |
dc.identifier.rcub | https://hdl.handle.net/21.15107/rcub_farfar_4893 | |
dc.type.version | publishedVersion | sr |